Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera

NCT00928707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea
DRUG: GIVINOSTAT (ITF2357) 50 mg b.i.d. + MTD Hydroxyurea

Sponsor

Italfarmaco